AbbVie Reports First-Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
AbbVie (ABBV) Tops Q1 EPS by 8c, Raises FY EPS Guidance
April 25, 2019 7:43 AM EDTAbbVie (NYSE: ABBV) reported Q1 EPS of $2.14, $0.08 better than the analyst estimate of $2.06. Revenue for the quarter came in at $7.83 billion versus the consensus estimate of $7.76 billion.
GUIDANCE:
AbbVie sees FY2019 EPS of $8.73-$8.83, versus the consensus of $8.69.
For earnings history and earnings-related data on AbbVie (ABBV) click here.
... More